Wednesday, 31 May 2017

Teva's migraine drug succeeds in late-stage study

(Reuters) - Teva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraine met the main goal in a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)